163 related articles for article (PubMed ID: 15742552)
1. Development of matrix-membrane transdermal drug delivery system for atenolol.
Gupta SP; Jain SK
Drug Deliv; 2004; 11(5):281-6. PubMed ID: 15742552
[TBL] [Abstract][Full Text] [Related]
2. Transdermal atenolol releasing system: an approach towards its development.
Gupta SP; Jain SK
J Drug Target; 2006 Nov; 14(9):607-13. PubMed ID: 17090396
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique--a tool for controlled transdermal delivery of ibuprofen.
Abioye AO; Issah S; Kola-Mustapha AT
Int J Pharm; 2015 Jul; 490(1-2):112-30. PubMed ID: 25997660
[TBL] [Abstract][Full Text] [Related]
4. Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation.
Srivastava AK; Wadhwa S; Ridhurkar D; Mishra B
Drug Dev Ind Pharm; 2005 May; 31(4-5):367-74. PubMed ID: 16093202
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo transdermal studies of atenolol using iontophoresis.
Inal O; Kiliçarslan M; Ari N; Baykara T
Acta Pol Pharm; 2008; 65(1):29-36. PubMed ID: 18536170
[TBL] [Abstract][Full Text] [Related]
6. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
Gao Y; Liang J; Liu J; Xiao Y
Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
[TBL] [Abstract][Full Text] [Related]
7. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
Rastogi V; Yadav P; Husain A; Verma A
Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride.
Jain SK; Chourasia MK; Sabitha M; Jain R; Jain AK; Ashawat M; Jha AK
Drug Deliv; 2003; 10(3):169-77. PubMed ID: 12944137
[TBL] [Abstract][Full Text] [Related]
10. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
Ramkanth S; Chetty CM; Sudhakar Y
Pak J Pharm Sci; 2014 Jan; 27(1):115-20. PubMed ID: 24374439
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of buccal patches for delivery of atenolol.
Adhikari SN; Nayak BS; Nayak AK; Mohanty B
AAPS PharmSciTech; 2010 Sep; 11(3):1038-44. PubMed ID: 20533098
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
[TBL] [Abstract][Full Text] [Related]
13. Transdermal drug delivery systems of a beta blocker: design, in vitro, and in vivo characterization.
Aqil M; Sultana Y; Ali A; Dubey K; Najmi AK; Pillai KK
Drug Deliv; 2004; 11(1):27-31. PubMed ID: 15168788
[TBL] [Abstract][Full Text] [Related]
14. Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
Kalita B; Das MK; Sarma M; Deka A
AAPS PharmSciTech; 2017 Apr; 18(3):629-645. PubMed ID: 27173988
[TBL] [Abstract][Full Text] [Related]
15. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
[TBL] [Abstract][Full Text] [Related]
16. Preparation of monolithic osmotic pump system by coating the indented core tablet.
Liu L; Che B
Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of carvedilol transdermal patches.
Tanwar YS; Chauhan CS; Sharma A
Acta Pharm; 2007 Jun; 57(2):151-9. PubMed ID: 17507312
[TBL] [Abstract][Full Text] [Related]
18. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
[TBL] [Abstract][Full Text] [Related]
19. Effect of polyunsaturated fatty acids and some conventional penetration enhancers on transdermal delivery of atenolol.
Puglia C; Bonina F
Drug Deliv; 2008 Feb; 15(2):107-12. PubMed ID: 18293196
[TBL] [Abstract][Full Text] [Related]
20. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
